Bioventus Receives FDA Clearance of Strip Format of its SIGNAFUSE® Bioactive Bone Graft DURHAM, NC – June 25, 2020 – Bioventus, a global leader in ort [...]

Bioventus Selects Bazis NN as Distributor of DUROLANE® in Russia HOOFDDORP, THE NETHERLANDS – June 15, 2020 – Bioventus, a global leader in orthobiolo [...]

Bioventus Announces Change in Chief Executive OfficerKen Reali Appointed to Succeed Tony Bihl Who Will Retire DURHAM, NC - March 25, 2020 – Tony Bihl, [...]

Bioventus Recognizes 25 Years of Proven Bone Healing from EXOGEN DURHAM, NC – February 24, 2020 – Bioventus, a global leader in orthobiologic solution [...]

Bioventus Updates US Label for EXOGEN® Ultrasound Bone Healing System DURHAM, NC – February 10, 2020 – Bioventus, a global leader in orthobiologic sol [...]

Bioventus to Provide Blue Cross Blue Shield of Michigan with Preferred Options for Knee Osteoarthritis Patients Products include DUROLANE®, GELSYN-3® [...]

Bioventus Launches New Website for Knee Osteoarthritis Pain Relief Information DURHAM, NC – October 10, 2019 – In support of World Arthritis Day, whic [...]

National Institute for Health and Clinical Excellence Maintains Previous Recommendation for EXOGEN® Ultrasound Bone Healing System HOOFDDORP, THE NETH [...]

Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans Members Have Access to DUROLANE® and GELSYN-3®for Knee Osteoarthritis [...]

Bioventus Launches DUROLANE® SJ (1mL) in Australia and New Zealand; Receives Expanded Indications for DUROLANE (3mL) HOOFDDORP, THE NETHERLANDS – [...]